Skip to main content
Premium Trial:

Request an Annual Quote

Martin Schmieg, Michael Kallelis, Paulette Gray


Martin Schmieg has been named CFO of Isolagen, the company said this week.

Schmieg was most recently CFO of Sirna Therapeutics, but left the Colorado-based company to pursue opportunities closer to his family and home in Philadelphia (see RNAi News, 4/8/2005).

Before joining Sirna, Schmieg was senior vice president and CFO at Advanced Bionics, where he helped oversee the company's sale to Boston Scientific, said Isolagen. Schmieg was also executive vice president of Cytometrics.

Archemix said this week that Michael Kallelis has been appointed vice president of manufacturing.

Before joining Archemix, Kallelis was executive vice president and general manager of Avecia Biotechnology. Prior to this, he co-founded and served as COO of Boston BioSystems, an oligonucleotide producer. Kallelis has also held positions with BioSepra and Millipore.

Paulette Gray has become director of the division of extramural activities of the National Cancer Institute, NCI said this week.

She had been the division's deputy director, then acting and deputy director, since 1997. The division of extramural activities coordinates all of NCI's extramural programs and grants.

Gray joined NCI in 1984 as a special review officer, moving to different positions from there. She holds a PhD in cellular and developmental biology and an MS in mycology from Atlanta University, and a BS in biology from Tuskegee University in Alabama.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.